Pharma Industry News
www.bayerhealthcare.com.www.bayerscheringpharma.de.www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Contact
Dr. Friederike...
ROCKVILLE, Md., Sept. 5, 2008--The U.S. Food and Drug Administration announced today that it has posted on its Web site its first quarterly report that lists certain drugs that are being evaluated for potential safety issues. The drugs have been...
ATLANTA, September 05, 2008 /PRNewswire/ -- EthicAd, a nonprofit organization devoted to improving public health through consumer education, announces the launch of a new FDA Web site created to help the general public better understand...
WASHINGTON, Sept. 2, 2008 - The House Committee on Energy and Commerce today posted on its website a letter sent to the CEOs of Schering-Plough and Merck & Co. over the SEAS study. The letter is...
THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Sep 4, 2008 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety...
WINSTON-SALEM, N.C., Sept. 5, 2008– Free drug samples provided to physicians by pharmaceutical companies could actually be costing uninsured patients more in the long run, according to a study done by researchers at Wake Forest University...
Agency invokes new authorities under FDAAA to alert patients and prescribers to risk
ROCKVILLE, Md., Sept. 4, 2008-The U.S. Food and Drug Administration today announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen...
Access to New Treatment is Needed to Manage Prescription Painkiller
Dependence Without Risk of Overdose or Misuse
KIRKLAND, QC, Sept. 3 /CNW/ - Prescription painkiller dependence is a serious problem in Ontario, according to the results of a new...
PHILADELPHIA, September 03, 2008 /PRNewswire-FirstCall/ -- GlaxoSmithKline announced today the launch of the RELENZA(R) (zanamivir) Inhalation Powder Pandemic Readiness for Employers Program (P.R.E.P.) that enables businesses two options when...
YONKERS, N.Y., September 02, 2008 /PRNewswire-USNewswire/-- Consumer Reports advises people who suffer from frequent headaches to talk to their doctors before reaching again into their medicine cabinets. Overuse of prescription and over-the-counter...
ROCKVILLE, Md., Sept. 2, 2008--FDA approved, on August 29, 2008, changes to the product label for Norvir (ritonavir) Soft Gelatin Capsules, and Norvir Oral Solution reflecting new, post marketing information regarding QT/QTc interval and PR interval...
OSAKA, Japan & PALO ALTO, Calif.--(BUSINESS WIRE)--Aug 28, 2008 - Takeda Pharmaceutical Company Limited (TOKYO:4502) and Affymax, Inc. (Nasdaq:AFFY) today announced their agreement to suspend co-development of Hematide(TM) to treat...
BOSTON, Mass. (September 1, 2008)—Direct-to-consumer advertising may not be giving big pharma such a big bang for their buck after all. Despite the billions spent on bringing drug marketing campaigns straight into patients' living rooms, such...
LONDON, & ALISO VIEJO, California, Aug. 28, 2008-GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (NYSE: VRX) today announced that they have entered into an exclusive worldwide collaboration agreement for the investigational drug...
NICE Final Guidance Recommends Lucentis As Cost-Effective Treatment for Wet AMD, a Leading Cause of Blindness
Lucentis is only approved therapy to demonstrate improvement in vision and vision-related function in vast majority of wet AMD...
- Clinical data showing unprecedented 89% reduction in risk of GIST relapse with use of Gleevec after surgery are basis for FDA, EMEA, Swissmedic filings
EAST HANOVER, N.J., August 27, 2008 /PRNewswire/ -- Novartis announced today that Gleevec(R)...
SAN DIEGO and INDIANAPOLIS, August 26, 2008 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company in a conference call today provided context and additional information regarding the August 18, 2008 U.S. Food and Drug...
Information for Healthcare Professionals Natalizumab Injection for Intraveneous Use (marketed as Tysabri)
ROCKVILLE, Md., Aug. 25, 2008--FDA ALERT [8/2008]: The FDA has recently received information from the manufacturer about two new cases of...
Diabetes sites gain popularity as treatment options change
NEW YORK, August 25, 2008 /PRNewswire/ -- Diabetes treatment brand sites from Januvia, Actos, Byetta, and Avandia are among the top pharmaceutical product websites in terms of primary care...
MIAMI--(BUSINESS WIRE)--Aug 25, 2008 - Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today provided an update on the status of Daytrana(R), the only transdermal patch indicated for the treatment of the symptoms of Attention Deficit Hyperactivity...
More...Pharma Industry News Archive
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
